fluorodeoxyglucose f18 has been researched along with Angiomatosis Retinae in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Koyasu, S; Matsunaga, M; Nakamoto, Y; Sugimoto, A; Tsukamoto, S | 1 |
| Banezhad, F; Emami, F; Kiamanesh, Z; Sadeghi, R | 1 |
| Agrawal, A; Kulkarni, M; Purandare, N; Rangarajan, V; Shah, S; Zade, A | 1 |
| Alimchandani, M; Ellis, R; Kebebew, E; Linehan, WM; Millo, C; Nilubol, N; Patel, D; Quezado, M; Sadowski, SM; Venzon, DJ; Weisbrod, AB | 1 |
| Bagci, U; Jassel, IS; Karantanas, AH; Millo, C; Papadakis, GZ; Patronas, NJ; Sadowski, SM | 1 |
| Campbell, P; Kok, J; Lin, M; Lin, P; Wong, V | 1 |
| Gesuwan, K; Herscovitch, P; Hughes, MS; Kebebew, E; Kitano, M; Libutti, SK; Linehan, WM; Millo, C; Nilubol, N; Phan, GQ; Rahbari, R; Venkatesan, AM; Webb, RC | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Angiomatosis Retinae
| Article | Year |
|---|---|
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
Topics: Adolescent; Adult; Aged; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease; Young Adult | 2011 |
6 other study(ies) available for fluorodeoxyglucose f18 and Angiomatosis Retinae
| Article | Year |
|---|---|
A Von Hippel-Lindau Disease-Associated Microcystic Adenoma of the Ethmoid Sinus Mimicking Metastatic Clear Cell Renal Cell Carcinoma.
Topics: Adenoma; Adult; Carcinoma, Renal Cell; Ethmoid Sinus; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; von Hippel-Lindau Disease | 2023 |
68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Topics: Adult; Cerebellar Neoplasms; Fluorodeoxyglucose F18; Hemangioblastoma; Humans; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin; von Hippel-Lindau Disease | 2019 |
FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; von Hippel-Lindau Disease | 2013 |
Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions.
Topics: Adolescent; Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; von Hippel-Lindau Disease; Young Adult | 2014 |
18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma.
Topics: Adult; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hemangioblastoma; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Retinal Neoplasms; von Hippel-Lindau Disease | 2017 |
[18F]FDG PET/CT in pancreatic neuroendocrine tumours associated with von Hippel Lindau Syndrome.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed; von Hippel-Lindau Disease | 2009 |